Markets Up on China: Rewind (1/10)

Jan. 10 (Bloomberg) -- Today's "Rewind" includes segments such as Market Timeline, a Market Road Map, and Top Headlines. (Source: Bloomberg)
Inside Johnson & Johnson's Earnings Beat
05:53 - Johnson & Johnson beat analysts’ estimates for third-quarter profit as a lower tax rate helped the world’s biggest maker of health-care products overcome slightly weaker-than-projected sales for key drugs such as Remicade. Gabelli & Co.'s Jeff Jonas and Bloomberg's Cynthia Koons weigh in on "Bloomberg Markets." Jonas owns no stock in J&J. (Source: Bloomberg)
  • Have We Hit the Bottom in Commodity Prices?
  • Why Market Correction Didn't Change the M&A Pipeline
  • Norway's Oil: What'd You Miss?: (Full Show 10/12)